A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction
about
GABA A receptors: subtypes provide diversity of function and pharmacologyInternational Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. UpdateRealistic expectations of prepulse inhibition in translational models for schizophrenia research.The anti-convulsant stiripentol acts directly on the GABA(A) receptor as a positive allosteric modulatorModifications of antiepileptic drugs for improved tolerability and efficacyOrganization of GABAergic synaptic circuits in the rat ventral tegmental areaMolecular basis of the γ-aminobutyric acid A receptor α3 subunit interaction with the clustering protein gephyrinGABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism.Diversity of neuronal inhibition: a path to novel treatments for neuropsychiatric disorders.Postmortem brain: an underutilized substrate for studying severe mental illnessAdministration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia.The Buzz about anabolic androgenic steroids: electrophysiological effects in excitable tissues.Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition15N-labeled brain enables quantification of proteome and phosphoproteome in cultured primary neurons.Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia.Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsPrepulse inhibition and genetic mouse models of schizophrenia.GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.A gain in GABAA receptor synaptic strength in thalamus reduces oscillatory activity and absence seizures.The evolution of drug development in schizophrenia: past issues and future opportunities.Behavioral genetic contributions to the study of addiction-related amphetamine effects.Quantitative trait locus analysis identifies Gabra3 as a regulator of behavioral despair in mice.A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation.Quantitative organization of GABAergic synapses in the molecular layer of the mouse cerebellar cortexNeural bases for addictive properties of benzodiazepines.Association of TMEM18 variants with BMI and waist circumference in children and correlation of mRNA expression in the PFC with body weight in ratsSB-205384 is a positive allosteric modulator of recombinant GABAA receptors containing rat α3, α5, or α6 subunit subtypes coexpressed with β3 and γ2 subunits.Novel β-catenin target genes identified in thalamic neurons encode modulators of neuronal excitability.Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice.Effect of genetic and pharmacological blockade of GABA receptors on the 5-HT2C receptor function during stress.The effects of stiripentol on GABA(A) receptorsNovel roles for immune molecules in neural development: implications for neurodevelopmental disorders.Central and Peripheral GABA(A) Receptor Regulation of the Heart Rate Depends on the Conscious State of the Animal.Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes.A case of GABAR antibodies in schizophreniaLinking GABA(A) receptor subunits to alcohol-induced conditioned taste aversion and recovery from acute alcohol intoxication.Enrichment of GABAA Receptor α-Subunits on the Axonal Initial Segment Shows Regional DifferencesGABAA receptors in central nervous system disease: anxiety, epilepsy, and insomnia.
P2860
Q24599057-8A682970-C49B-4EAE-9B7A-F45F8D70B527Q24608968-0030315F-3F42-4B0F-BD46-30CBC050D222Q24645703-CBABE66B-4E4A-4FC7-AD77-FC5AD510C313Q24646448-ACCD2F81-C071-4A13-A1D0-9023AEE29984Q24651951-C539A199-A34A-45B7-937C-2AAD070EFC87Q28484279-3F369695-991B-4194-AC90-45A42E6C1A80Q28574183-5E31DF18-E969-4B3C-9FA6-3D51A936D05FQ30363617-DE03F85C-0531-4A92-9289-92EDA8F5F5FDQ30421260-F74EC3A7-1EB5-48EF-A661-85E5B28F01A7Q30421954-8A2A4555-3318-4D11-A501-7A394CC54488Q30422050-CAEF1B11-C165-473E-9A81-651885543D39Q30427268-911BB766-B3E5-425F-ACD1-1C3B5ABF3386Q30449339-6623A14A-84F0-4D54-B4B6-63E90A8CDD33Q30458275-8AAC5AD2-EC4D-4813-8042-BC863D17232EQ30458503-B3DF07D1-EA24-4055-9F65-64174B89E2BCQ30466591-61CBF7E1-FFF2-4089-B280-9A6212CAC742Q30473410-09075BEC-8658-4D5A-A447-22CBAC2C6E85Q30476813-4993433A-4980-41EB-B3B9-642C253DE7E6Q30478270-43644684-31C5-4DF0-9CDF-DF32860C4C01Q30479407-01EF9BC3-3C69-43F3-B329-DDF1BE273FDEQ30487472-EC131152-1DF0-46A9-BB94-5B6BAE5B3441Q30487850-7326C7A1-1ECA-4C54-9C53-EFA210BA675FQ30494693-3767160B-F6E3-4166-BCE1-FC4465D2F7D3Q30495091-11FB5CC5-A77D-49CF-B7F8-07AA19D34CD3Q30538580-B3372886-2F6E-481E-A875-9A4AD00CF9A7Q33658632-B37865F7-F091-4319-878A-5E6EAF214013Q33855956-160C7B30-4EBE-495B-9F52-F45CC741A24BQ34032953-E4F04B86-9E3E-470C-89E1-6709B47AE10EQ34360939-E4E9D271-07F0-4110-AD48-FDE2A9D21976Q34479682-B6667607-1002-4A0A-BF86-2A716373C75EQ34512419-006C560C-F729-41FC-83DF-2C730F078024Q34543652-2D20D409-5B32-4794-B0CC-11A9205A9EC3Q34660454-8C53C979-11D2-4EAC-9A96-3A6CDCDA8887Q34689823-21C194D3-D76E-4D31-846D-F73105673972Q35579379-EA85C650-3C21-4B2A-A6B9-111280FE772CQ35924378-6A398CF3-88F0-46C6-A256-72D4B2DEFD5AQ36244627-553B4D54-710C-446D-9AEC-83A092A476FDQ36582066-F0693B72-6495-4051-BD6E-7FF77E4D9076Q36632594-2ECA843C-598A-4B05-B07E-FEB4EEA53CF8Q36659853-504C6C90-989C-49C8-8CD0-8F4D0A87DAC9
P2860
A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A schizophrenia-related sensor ...... rs to a dopamine hyperfunction
@ast
A schizophrenia-related sensor ...... rs to a dopamine hyperfunction
@en
type
label
A schizophrenia-related sensor ...... rs to a dopamine hyperfunction
@ast
A schizophrenia-related sensor ...... rs to a dopamine hyperfunction
@en
prefLabel
A schizophrenia-related sensor ...... rs to a dopamine hyperfunction
@ast
A schizophrenia-related sensor ...... rs to a dopamine hyperfunction
@en
P2093
P2860
P356
P1476
A schizophrenia-related sensor ...... rs to a dopamine hyperfunction
@en
P2093
H Bluethmann
L von Boehmer
N Hagenbuch
R C Malenka
P2860
P304
17154-17159
P356
10.1073/PNAS.0508752102
P407
P577
2005-11-11T00:00:00Z